Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron rises on strong FY24 sales and upbeat outlook

** Shares of Immuron  IMC.AX  rise as much as 10.5% to
A$0.095, their highest since June 3
    ** Stock posts its biggest intraday pct gain since April 10
    ** Biopharmaceutical co posts FY24 global sales of A$4.9 mln
($3.32 mln), up 174% on pcp
    ** Says achieved record FY24 sales in the United States with
A$1.1 mln, up 74% from the previous year
    ** Says it hopes to achieve strong North American growth in
FY25 on the back of planned increased brand investment and
distribution
    ** More than 943,200 shares change hands, compared with the
30-day average volume of 136,929
    ** Stock had risen 11.7% this year, as of last close

($1 = 1.4767 Australian dollars)

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))

Recent news on Immuron

See all news